These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15369199)

  • 21. MDMA misrepresentation: an unresolved problem for Ecstasy users.
    Hayner GN
    J Psychoactive Drugs; 2002; 34(2):195-8. PubMed ID: 12691209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.
    Brunt TM; Niesink RJ; van den Brink W
    Int J Drug Policy; 2012 Mar; 23(2):134-40. PubMed ID: 21741814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees.
    Yacoubian GS; Miller S; Pianim S; Kunz M; Orrick E; Link T; Palacios WR; Peters RJ
    J Drug Educ; 2004; 34(1):41-59. PubMed ID: 15468747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A profile of Ecstasy (MDMA) use in São Paulo, Brazil: an ethnographic study.
    Battisti MC; Noto AR; Nappo S; Carlini Ede A
    J Psychoactive Drugs; 2006 Mar; 38(1):13-8. PubMed ID: 16681171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Getting into ecstasy: comparing moderate and heavy young adult users.
    Sterk CE; Theall KP; Elifson KW
    J Psychoactive Drugs; 2007 Jun; 39(2):103-13. PubMed ID: 17703705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Parrott AC; Buchanan T; Scholey AB; Heffernan T; Ling J; Rodgers J
    Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDMA ('ecstasy') and other 'club drugs'. The new epidemic.
    Koesters SC; Rogers PD; Rajasingham CR
    Pediatr Clin North Am; 2002 Apr; 49(2):415-33. PubMed ID: 11993291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA.
    Haug NA; Wadekar R; Barry R; Sottile J
    J Psychoactive Drugs; 2024; 56(3):412-421. PubMed ID: 37384948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K; Redman J
    Drug Alcohol Depend; 2006 Apr; 82(2):168-76. PubMed ID: 16226850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex, touch, and HIV risk among ecstasy users.
    Theall KP; Elifson KW; Sterk CE
    AIDS Behav; 2006 Mar; 10(2):169-78. PubMed ID: 16456728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The health effects of ecstasy: a literature review.
    Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL
    Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.
    Murphy PN; Wareing M; Fisk J
    J Psychopharmacol; 2006 May; 20(3):447-55. PubMed ID: 16574719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual identity and drug use harm among high-risk, active substance users.
    Chow C; Vallance K; Stockwell T; Macdonald S; Martin G; Ivsins A; Marsh DC; Michelow W; Roth E; Duff C
    Cult Health Sex; 2013; 15(3):311-26. PubMed ID: 23311592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.
    George J; Kinner SA; Bruno R; Degenhardt L; Dunn M
    Drug Alcohol Rev; 2010 May; 29(3):243-9. PubMed ID: 20565515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative experiences on Ecstasy: the role of drug, set and setting.
    McElrath K; McEvoy K
    J Psychoactive Drugs; 2002; 34(2):199-208. PubMed ID: 12691210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.